Source: University of Minnesota
Date: May 8, 2008
Summary:
Researchers at the University of Minnesota’s Diabetes Institute for Immunology and Transplantation announce the start of new clinical trials for people with type 1 diabetes. The University is one of only seven sites in the United States funded by the National Institutes of Health as part of the Clinical Islet Transplantation Consortium, the goal of which is to determine whether islet transplantation becomes an FDA-approved treatment for people with difficult-to-manage type 1 diabetes.
